Preclinical Tests Show Acid-Sensitive Nanoparticles Treat Ovarian Cancers With Little Toxicity

Published: Aug 29, 2006

Last year, members of the Alliance for Nanotechnology in Cancer based at Northeastern University and the Massachusetts Institute of Technology demonstrated that acid-sensitive polymer nanoparticles could boost the delivery of anticancer drugs into the acidic interior of tumors.

>>> Discuss This Story

Back to news